The Commerce Commission has received an application from Pfizer Inc. seeking clearance to acquire Wyeth Corp.
Pfizer operates in New Zealand through its subsidiary, Pfizer New Zealand Limited, which supplies a number of human health and animal health products.
Wyeth supplies a number of human health products in New Zealand through its subsidiary, Wyeth (New Zealand) Limited. It also supplies various animal health products in New Zealand through its subsidiary, Fort Dodge New Zealand Limited.
In considering the application, the Commission's role is to determine whether the acquisition has the effect of substantially lessening competition in a market.
A public version of the application will shortly be available on the Commission's website www.comcom.govt.nz under the Clearances Register. A statement of preliminary issues, outlining the Commission's view on the competition issues that could arise if the proposed merger were to proceed, will also be released shortly.
